Glucuronolactone Market
Market Insights on Glucuronolactone covering sales outlook, demand forecast & up-to-date key trends
Glucuronolactone Market by End-use, Form & Region - Forecast 2022 – 2032
Glucuronolactone Market Outlook (2022-2032)
[306 Pages Report]The global glucuronolactone market is estimated to reach a market valuation of USD 350.1 Mn by the year 2022, accelerating with a CAGR of 5.9% by 2022-2032. Glucuronolactone market is used as a food additive in food and functional beverages. In terms of purity, 0.99% grade of Glucuronolactone is highly preferable among manufacturers. Increasing consumption of energy drinks is one of the key factors fuelling the demand for Glucuronolactone in the market.
|
Glucuronolactone Market Size (2022E) |
USD 350.1 Mn |
|
Glucuronolactone Market Projected Size (2032F) |
USD 624.0 Mn |
|
Value CAGR (2022-2032) |
5.9% |
|
Top 3 Countries’ Market Share |
38.4% |
Glucuronolactone is an odorless, white solid substance found in people, animals, and the gums of plants. It is a vital component of all linked tissues. It is a chemical created by the human liver's glucose metabolism. Glucuronolactone is a component of connective tissues as well as an important antioxidant in the production of ascorbic acid.
Because of its numerous health benefits, the increasing adoption of glucuronolactone from various end-use industries such as pharmaceuticals and food and beverages is a significant factor contributing to the growth glucuronolactone market. Some factors expected to drive the glucuronolactone market during the forecast period include increased use of glucuronolactone as an ingredient in functional foods and energy drinks to act as a potent antioxidant and eliminate harmful chemicals through waste from the body, fueled by increased consumer health awareness.
Let us know your requirement to get
100% FREE customization
Glucuronolactone Market Historic and Future Outlook Compare
Glucuronolactone sales grew at a CAGR of 5.4% between 2017 and 2022. The period marked the entry of various market players and product innovations.
In pharmaceuticals, glucuronolactone is frequently used as a component in the production of a range of treatment options for food and drug poisoning, hepatitis, and immune response modulation. A rise in demand from bodybuilders and athletes is also expected to contribute to market expansion.
High glucuronolactone prices, as well as various negative impacts related to excessive glucuronolactone intakes, such as dizziness, disorientation, and fast heartbeat, are anticipated to hamper the market growth during the forecast period.
Glucuronolactone-Based Dietary Supplements Are Becoming More Popular
The human brain, liver, and heart contain glucuronolactone, which is involved in a range of physiological functions. Some of its metabolic roles include osmoregulation, membrane stability, and bile acid conjugation. Cardiovascular disease, retinal degeneration, and epilepsy are all diseases that can be caused by glucuronolactone shortage.
Glucuronolactone supplementation has been demonstrated to be beneficial to one's health. This indeed is increasing the demand for dietary supplements around the world as people grow more concerned about their health.
Furthermore, this has increased demand for glucuronolactone-containing supplements, resulting in market expansion. The rise in demand from the pharmaceutical and food & beverage industries, as well as increased awareness about a healthy lifestyle, are two major factors driving the glucuronolactone market.
However, glucuronolactone's unfavorable health effects may limit total market growth in the coming years. Furthermore, the pharmaceutical industry is predicted to grow at the quickest CAGR in the next years as people become more concerned about their health.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystGlucuronolactone-Based Dietary Supplements Are Becoming More Popular
The human brain, liver, and heart contain glucuronolactone, which is involved in a range of physiological functions. Some of its metabolic roles include osmoregulation, membrane stability, and bile acid conjugation. Cardiovascular disease, retinal degeneration, and epilepsy are all diseases that can be caused by glucuronolactone shortage.
Glucuronolactone supplementation has been demonstrated to be beneficial to one's health. This indeed is increasing the demand for dietary supplements around the world as people grow more concerned about their health.
Furthermore, this has increased demand for glucuronolactone-containing supplements, resulting in market expansion. The rise in demand from the pharmaceutical and food & beverage industries, as well as increased awareness about a healthy lifestyle, are two major factors driving the glucuronolactone market. However, glucuronolactone's unfavorable health effects may limit total market growth in the coming years.
Furthermore, the pharmaceutical industry is predicted to grow at the quickest CAGR in the next years as people become more concerned about their health.
Country-wise Insights
Sales of Glucuronolactone in the US
The US accounted for 89.4% of the total market in 2022 in North America and is expected to rise significantly due to the widespread use of glucuronolactone as a nutritional supplement in the country.
Additionally, glucuronolactone-containing drinks have been very popular in the country, and companies like Rockstar Inc., Red Bull, and Monster have released numerous glucuronolactone-containing drinks, which will offer enormous potential throughout the projected period. However, due to restrictions on the use of glucuronolactone in traditional beverages, the majority of these drinks are sold as supplements.
Consumption of Glucuronolactone in the United Kingdom
The use of glucuronolactone in prescription medications for the treatment of collagen disease, hepatitis, and bone illnesses in the United Kingdom, and Europe is predicted to increase at a CAGR of 6.9% from 2022 to 2032. In addition, government backing, together with increased R&D expenditure, is predicted to contribute significantly to market growth.
Rising Demand for Glucuronolactone in China
The high number of glucuronolactone producers in China and the high level of exports are expected to increase at a CAGR of 7.8% from 2022 to 2032. Furthermore, the product's widespread availability in China is projected to benefit the market in the approaching years. The pharmaceutical industry in China, India, Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam is expanding.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-wise Insights
Glucuronolactone Application in Pharmaceuticals Accounting for a Prominent Share
As a result of the increased application of glucuronolactone-based pills and supplements to treat hepatocirrhosis, arthritis, and hepatitis, the pharmaceutical application will rise at the fastest rate, with a CAGR of 7.0% from 2022 to 2032. Furthermore, market growth is likely to be fueled by the recovery of the pharmaceutical industry in the United States over the forecast period.
Powder Form of Glucuronolactone Accounting for Significant Share
The powder form of glucuronolactone is projected to account for the highest significant share as consumers are consuming it as a dietary supplement over the projection period, a growing health-conscious population in the urban area is expected to boost demand growth for powder glucuronolactone.
Competitive Landscape
Some of the key players operating in the glucuronolactone market are Shaoxing Marina Biotechnology Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Functional Food chem International Corporation, Merck Millipore Corporation, Jungbunzlauer, Shandong Fuyuan Bio-Tech CO.LTD. Roquette Frères, Shandong Xinhong Pharmaceutical Co., Ltd., Shandong Baisheng Biotechnology Co., Ltd., and others.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2022-2032 |
|
Historical Data Available for |
2017-2021 |
|
Market Analysis |
USD Mn for Value and Metric Ton for Volume |
|
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa |
|
Key Countries Covered |
United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Singapore, Australia, New Zealand, GCC countries, North Africa, South Africa, others. |
|
Key Segments Covered |
End-use, Form and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Glucuronolactone Market by Category
By Form, Glucuronolactone Market is Segmented as:
- Powder
- Liquid
- Tablet & Capsules
By End Use, Glucuronolactone Market is Segmented as:
- Dietary Supplement
- Energy Drinks
- Pharmaceuticals
- Cosmetics
- Functional Food
By Region, Glucuronolactone Market is Segmented as:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa
Frequently Asked Questions
The glucuronolactone market will reach nearly USD 350.1 Mn by 2022.
The glucuronolactone market is anticipated to reach a valuation of USD 624.0 Mn by 2032 end.
The glucuronolactone market is expected to register a 5.9% CAGR between 2022 and 2032.
Demand for glucuronolactone in North America countries is anticipated to drive the demand during the forecast period of 2022 to 2032.
A few of the key players in the market are Shaoxing Marina Biotechnology Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Merck Millipore Corporation, Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Functional Food chem International Corporation, Jungbunzlauer, Shandong Fuyuan Bio-Tech CO.LTD. Roquette Frères, Shandong Xinhong Pharmaceutical Co., Ltd., and Shandong Baisheng Biotechnology Co., Ltd. among Others.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Product launches & Recent Developments
3.4. Product Life Cycle Analysis
3.5. Value Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. % of Operating Margin Analysis
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Global Drinkable Yogurt Market - Pricing Analysis
3.6.1. Price Point Assessment by Region
3.6.2. Price Point Assessment by Product Type
3.6.3. Price Forecast till 2032
3.6.4. Factors affecting Pricing
3.7. Forecast Factors - Relevance & Impact
3.8. Regulatory Landscape
3.8.1. Packaging & Labelling Regulations
3.8.2. Certifications and Certifying Agency Overview
3.8.3. Import/Export Policies
3.9. Regional Parent Market Outlook
3.10. Consumers Survey Analysis
3.11. Macro-Economic Factors
3.12. Product Claims & Nutritional Information Scan by Buyers
4. Global Glucuronolactone Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (MT) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Form
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Form , 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Form , 2022-2032
5.3.1. Powder
5.3.2. Liquid
5.3.3. tablet & Capsules
5.4. Y-o-Y Growth Trend Analysis By Form , 2017-2021
5.5. Absolute $ Opportunity Analysis By Form , 2022-2032
6. Global Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By End Use Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By End Use Application, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By End Use Application, 2022-2032
6.3.1. Dietary Supplements
6.3.2. Pharmaceutical
6.3.3. Cosmetics
6.3.4. Energy Drinks
6.3.5. Food ( tofu, meat products, etc.)
6.4. Y-o-Y Growth Trend Analysis By End Use Application, 2017-2021
6.5. Absolute $ Opportunity Analysis By End Use Application, 2022-2032
7. Global Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. East Asia
7.3.5. South Asia
7.3.6. Oceania
7.3.7. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Form
8.2.3. By End Use Application
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Form
8.3.3. By End Use Application
8.4. Key Takeaways
9. Latin America Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Argentina
9.2.1.4. Chile
9.2.1.5. Peru
9.2.1.6. Rest of Latin America
9.2.2. By Form
9.2.3. By End Use Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Form
9.3.3. By End Use Application
9.4. Key Takeaways
10. Europe Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. Italy
10.2.1.3. France
10.2.1.4. U.K.
10.2.1.5. Spain
10.2.1.6. Russia
10.2.1.7. BENELUX
10.2.1.8. Poland
10.2.1.9. Nordic Countries
10.2.1.10. Rest of Europe
10.2.2. By Form
10.2.3. By End Use Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Form
10.3.3. By End Use Application
10.4. Key Takeaways
11. East Asia Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.2. By Form
11.2.3. By End Use Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Form
11.3.3. By End Use Application
11.4. Key Takeaways
12. South Asia Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Thailand
12.2.1.3. Malaysia
12.2.1.4. Indonesia
12.2.1.5. Rest of South Asia
12.2.2. By Form
12.2.3. By End Use Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Form
12.3.3. By End Use Application
12.4. Key Takeaways
13. Oceania Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Form
13.2.3. By End Use Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Form
13.3.3. By End Use Application
13.4. Key Takeaways
14. MEA Glucuronolactone Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Central Africa
14.2.1.4. North Africa
14.2.2. By Form
14.2.3. By End Use Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Form
14.3.3. By End Use Application
14.4. Key Takeaways
15. Key Countries Glucuronolactone Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Form
15.1.2.2. By End Use Application
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Form
15.2.2.2. By End Use Application
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Form
15.3.2.2. By End Use Application
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Form
15.4.2.2. By End Use Application
15.5. Argentina
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Form
15.5.2.2. By End Use Application
15.6. Chile
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Form
15.6.2.2. By End Use Application
15.7. Peru
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Form
15.7.2.2. By End Use Application
15.8. Germany
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Form
15.8.2.2. By End Use Application
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Form
15.9.2.2. By End Use Application
15.10. France
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Form
15.10.2.2. By End Use Application
15.11. Spain
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Form
15.11.2.2. By End Use Application
15.12. U.K.
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Form
15.12.2.2. By End Use Application
15.13. Russia
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Form
15.13.2.2. By End Use Application
15.14. Poland
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Form
15.14.2.2. By End Use Application
15.15. BENELUX
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Form
15.15.2.2. By End Use Application
15.16. Nordic Countries
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Form
15.16.2.2. By End Use Application
15.17. China
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Form
15.17.2.2. By End Use Application
15.18. Japan
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Form
15.18.2.2. By End Use Application
15.19. South Korea
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Form
15.19.2.2. By End Use Application
15.20. India
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Form
15.20.2.2. By End Use Application
15.21. Thailand
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2021
15.21.2.1. By Form
15.21.2.2. By End Use Application
15.22. Indonesia
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2021
15.22.2.1. By Form
15.22.2.2. By End Use Application
15.23. Malaysia
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2021
15.23.2.1. By Form
15.23.2.2. By End Use Application
15.24. Singapore
15.24.1. Pricing Analysis
15.24.2. Market Share Analysis, 2021
15.24.2.1. By Form
15.24.2.2. By End Use Application
15.25. GCC Countries
15.25.1. Pricing Analysis
15.25.2. Market Share Analysis, 2021
15.25.2.1. By Form
15.25.2.2. By End Use Application
15.26. South Africa
15.26.1. Pricing Analysis
15.26.2. Market Share Analysis, 2021
15.26.2.1. By Form
15.26.2.2. By End Use Application
15.27. Central Africa
15.27.1. Pricing Analysis
15.27.2. Market Share Analysis, 2021
15.27.2.1. By Form
15.27.2.2. By End Use Application
15.28. North Africa
15.28.1. Pricing Analysis
15.28.2. Market Share Analysis, 2021
15.28.2.1. By Form
15.28.2.2. By End Use Application
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Form
16.3.3. By End Use Application
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Shaoxing Marina Biotechnology Co.Ltd.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Hubei Yitai Pharmaceutical Co.Ltd.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Merck Millipore Corporation
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Anhui Fubore Pharmaceutical & Chemical Co.Ltd.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Functional Food chem International Corporation
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Jungbunzlauer
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Shandong Fuyuan Bio-Tech CO.LTD.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Roquette Frères
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Shandong Xinhong Pharmaceutical Co., Ltd.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Shandong Baisheng Biotechnology Co., Ltd.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. Ceto Coorporation
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Creative Compound
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
17.1.13. Foodchem International
17.1.13.1. Overview
17.1.13.2. Product Portfolio
17.1.13.3. Profitability by Market Segments
17.1.13.4. Sales Footprint
17.1.13.5. Strategy Overview
17.1.13.5.1. Marketing Strategy
17.1.13.5.2. Product Strategy
17.1.13.5.3. Channel Strategy
17.1.14. Merck Millipore
17.1.14.1. Overview
17.1.14.2. Product Portfolio
17.1.14.3. Profitability by Market Segments
17.1.14.4. Sales Footprint
17.1.14.5. Strategy Overview
17.1.14.5.1. Marketing Strategy
17.1.14.5.2. Product Strategy
17.1.14.5.3. Channel Strategy
17.1.15. Others (on additional request)
17.1.15.1. Overview
17.1.15.2. Product Portfolio
17.1.15.3. Profitability by Market Segments
17.1.15.4. Sales Footprint
17.1.15.5. Strategy Overview
17.1.15.5.1. Marketing Strategy
17.1.15.5.2. Product Strategy
17.1.15.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Glucuronolactone Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Glucuronolactone Volume (MT) Forecast by Region, 2017-2032
Table 3: Global Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032
Table 4: Global Glucuronolactone Volume (MT) Forecast By Form , 2017-2032
Table 5: Global Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032
Table 6: Global Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032
Table 7: North America Glucuronolactone Value (US$ Mn) Forecast by Country, 2017-2032
Table 8: North America Glucuronolactone Volume (MT) Forecast by Country, 2017-2032
Table 9: North America Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032
Table 10: North America Glucuronolactone Volume (MT) Forecast By Form , 2017-2032
Table 11: North America Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032
Table 12: North America Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032
Table 13: Latin America Glucuronolactone Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Latin America Glucuronolactone Volume (MT) Forecast by Country, 2017-2032
Table 15: Latin America Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032
Table 16: Latin America Glucuronolactone Volume (MT) Forecast By Form , 2017-2032
Table 17: Latin America Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032
Table 18: Latin America Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032
Table 19: Europe Glucuronolactone Value (US$ Mn) Forecast by Country, 2017-2032
Table 20: Europe Glucuronolactone Volume (MT) Forecast by Country, 2017-2032
Table 21: Europe Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032
Table 22: Europe Glucuronolactone Volume (MT) Forecast By Form , 2017-2032
Table 23: Europe Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032
Table 24: Europe Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032
Table 25: East Asia Glucuronolactone Value (US$ Mn) Forecast by Country, 2017-2032
Table 26: East Asia Glucuronolactone Volume (MT) Forecast by Country, 2017-2032
Table 27: East Asia Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032
Table 28: East Asia Glucuronolactone Volume (MT) Forecast By Form , 2017-2032
Table 29: East Asia Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032
Table 30: East Asia Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032
Table 31: South Asia Glucuronolactone Value (US$ Mn) Forecast by Country, 2017-2032
Table 32: South Asia Glucuronolactone Volume (MT) Forecast by Country, 2017-2032
Table 33: South Asia Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032
Table 34: South Asia Glucuronolactone Volume (MT) Forecast By Form , 2017-2032
Table 35: South Asia Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032
Table 36: South Asia Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032
Table 37: Oceania Glucuronolactone Value (US$ Mn) Forecast by Country, 2017-2032
Table 38: Oceania Glucuronolactone Volume (MT) Forecast by Country, 2017-2032
Table 39: Oceania Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032
Table 40: Oceania Glucuronolactone Volume (MT) Forecast By Form , 2017-2032
Table 41: Oceania Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032
Table 42: Oceania Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032
Table 43: MEA Glucuronolactone Value (US$ Mn) Forecast by Country, 2017-2032
Table 44: MEA Glucuronolactone Volume (MT) Forecast by Country, 2017-2032
Table 45: MEA Glucuronolactone Value (US$ Mn) Forecast By Form , 2017-2032
Table 46: MEA Glucuronolactone Volume (MT) Forecast By Form , 2017-2032
Table 47: MEA Glucuronolactone Value (US$ Mn) Forecast by End Use Application, 2017-2032
Table 48: MEA Glucuronolactone Volume (MT) Forecast by End Use Application, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Glucuronolactone Value (US$ Mn) By Form , 2022-2032
Figure 2: Global Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032
Figure 3: Global Glucuronolactone Value (US$ Mn) by Region, 2022-2032
Figure 4: Global Glucuronolactone Value (US$ Mn) Analysis by Region, 2017-2032
Figure 5: Global Glucuronolactone Volume (MT) Analysis by Region, 2017-2032
Figure 6: Global Glucuronolactone Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 7: Global Glucuronolactone Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 8: Global Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032
Figure 9: Global Glucuronolactone Volume (MT) Analysis By Form , 2017-2032
Figure 10: Global Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032
Figure 11: Global Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032
Figure 12: Global Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032
Figure 13: Global Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032
Figure 14: Global Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032
Figure 15: Global Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032
Figure 16: Global Glucuronolactone Attractiveness By Form , 2022-2032
Figure 17: Global Glucuronolactone Attractiveness by End Use Application, 2022-2032
Figure 18: Global Glucuronolactone Attractiveness by Region, 2022-2032
Figure 19: North America Glucuronolactone Value (US$ Mn) By Form , 2022-2032
Figure 20: North America Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032
Figure 21: North America Glucuronolactone Value (US$ Mn) by Country, 2022-2032
Figure 22: North America Glucuronolactone Value (US$ Mn) Analysis by Country, 2017-2032
Figure 23: North America Glucuronolactone Volume (MT) Analysis by Country, 2017-2032
Figure 24: North America Glucuronolactone Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 25: North America Glucuronolactone Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 26: North America Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032
Figure 27: North America Glucuronolactone Volume (MT) Analysis By Form , 2017-2032
Figure 28: North America Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032
Figure 29: North America Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032
Figure 30: North America Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032
Figure 31: North America Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032
Figure 32: North America Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032
Figure 33: North America Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032
Figure 34: North America Glucuronolactone Attractiveness By Form , 2022-2032
Figure 35: North America Glucuronolactone Attractiveness by End Use Application, 2022-2032
Figure 36: North America Glucuronolactone Attractiveness by Country, 2022-2032
Figure 37: Latin America Glucuronolactone Value (US$ Mn) By Form , 2022-2032
Figure 38: Latin America Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032
Figure 39: Latin America Glucuronolactone Value (US$ Mn) by Country, 2022-2032
Figure 40: Latin America Glucuronolactone Value (US$ Mn) Analysis by Country, 2017-2032
Figure 41: Latin America Glucuronolactone Volume (MT) Analysis by Country, 2017-2032
Figure 42: Latin America Glucuronolactone Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 43: Latin America Glucuronolactone Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 44: Latin America Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032
Figure 45: Latin America Glucuronolactone Volume (MT) Analysis By Form , 2017-2032
Figure 46: Latin America Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032
Figure 47: Latin America Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032
Figure 48: Latin America Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032
Figure 49: Latin America Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032
Figure 50: Latin America Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032
Figure 51: Latin America Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032
Figure 52: Latin America Glucuronolactone Attractiveness By Form , 2022-2032
Figure 53: Latin America Glucuronolactone Attractiveness by End Use Application, 2022-2032
Figure 54: Latin America Glucuronolactone Attractiveness by Country, 2022-2032
Figure 55: Europe Glucuronolactone Value (US$ Mn) By Form , 2022-2032
Figure 56: Europe Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032
Figure 57: Europe Glucuronolactone Value (US$ Mn) by Country, 2022-2032
Figure 58: Europe Glucuronolactone Value (US$ Mn) Analysis by Country, 2017-2032
Figure 59: Europe Glucuronolactone Volume (MT) Analysis by Country, 2017-2032
Figure 60: Europe Glucuronolactone Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 61: Europe Glucuronolactone Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 62: Europe Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032
Figure 63: Europe Glucuronolactone Volume (MT) Analysis By Form , 2017-2032
Figure 64: Europe Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032
Figure 65: Europe Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032
Figure 66: Europe Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032
Figure 67: Europe Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032
Figure 68: Europe Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032
Figure 69: Europe Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032
Figure 70: Europe Glucuronolactone Attractiveness By Form , 2022-2032
Figure 71: Europe Glucuronolactone Attractiveness by End Use Application, 2022-2032
Figure 72: Europe Glucuronolactone Attractiveness by Country, 2022-2032
Figure 73: East Asia Glucuronolactone Value (US$ Mn) By Form , 2022-2032
Figure 74: East Asia Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032
Figure 75: East Asia Glucuronolactone Value (US$ Mn) by Country, 2022-2032
Figure 76: East Asia Glucuronolactone Value (US$ Mn) Analysis by Country, 2017-2032
Figure 77: East Asia Glucuronolactone Volume (MT) Analysis by Country, 2017-2032
Figure 78: East Asia Glucuronolactone Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 79: East Asia Glucuronolactone Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 80: East Asia Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032
Figure 81: East Asia Glucuronolactone Volume (MT) Analysis By Form , 2017-2032
Figure 82: East Asia Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032
Figure 83: East Asia Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032
Figure 84: East Asia Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032
Figure 85: East Asia Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032
Figure 86: East Asia Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032
Figure 87: East Asia Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032
Figure 88: East Asia Glucuronolactone Attractiveness By Form , 2022-2032
Figure 89: East Asia Glucuronolactone Attractiveness by End Use Application, 2022-2032
Figure 90: East Asia Glucuronolactone Attractiveness by Country, 2022-2032
Figure 91: South Asia Glucuronolactone Value (US$ Mn) By Form , 2022-2032
Figure 92: South Asia Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032
Figure 93: South Asia Glucuronolactone Value (US$ Mn) by Country, 2022-2032
Figure 94: South Asia Glucuronolactone Value (US$ Mn) Analysis by Country, 2017-2032
Figure 95: South Asia Glucuronolactone Volume (MT) Analysis by Country, 2017-2032
Figure 96: South Asia Glucuronolactone Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 97: South Asia Glucuronolactone Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 98: South Asia Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032
Figure 99: South Asia Glucuronolactone Volume (MT) Analysis By Form , 2017-2032
Figure 100: South Asia Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032
Figure 101: South Asia Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032
Figure 102: South Asia Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032
Figure 103: South Asia Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032
Figure 104: South Asia Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032
Figure 105: South Asia Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032
Figure 106: South Asia Glucuronolactone Attractiveness By Form , 2022-2032
Figure 107: South Asia Glucuronolactone Attractiveness by End Use Application, 2022-2032
Figure 108: South Asia Glucuronolactone Attractiveness by Country, 2022-2032
Figure 109: Oceania Glucuronolactone Value (US$ Mn) By Form , 2022-2032
Figure 110: Oceania Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032
Figure 111: Oceania Glucuronolactone Value (US$ Mn) by Country, 2022-2032
Figure 112: Oceania Glucuronolactone Value (US$ Mn) Analysis by Country, 2017-2032
Figure 113: Oceania Glucuronolactone Volume (MT) Analysis by Country, 2017-2032
Figure 114: Oceania Glucuronolactone Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 115: Oceania Glucuronolactone Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 116: Oceania Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032
Figure 117: Oceania Glucuronolactone Volume (MT) Analysis By Form , 2017-2032
Figure 118: Oceania Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032
Figure 119: Oceania Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032
Figure 120: Oceania Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032
Figure 121: Oceania Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032
Figure 122: Oceania Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032
Figure 123: Oceania Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032
Figure 124: Oceania Glucuronolactone Attractiveness By Form , 2022-2032
Figure 125: Oceania Glucuronolactone Attractiveness by End Use Application, 2022-2032
Figure 126: Oceania Glucuronolactone Attractiveness by Country, 2022-2032
Figure 127: MEA Glucuronolactone Value (US$ Mn) By Form , 2022-2032
Figure 128: MEA Glucuronolactone Value (US$ Mn) by End Use Application, 2022-2032
Figure 129: MEA Glucuronolactone Value (US$ Mn) by Country, 2022-2032
Figure 130: MEA Glucuronolactone Value (US$ Mn) Analysis by Country, 2017-2032
Figure 131: MEA Glucuronolactone Volume (MT) Analysis by Country, 2017-2032
Figure 132: MEA Glucuronolactone Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 133: MEA Glucuronolactone Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 134: MEA Glucuronolactone Value (US$ Mn) Analysis By Form , 2017-2032
Figure 135: MEA Glucuronolactone Volume (MT) Analysis By Form , 2017-2032
Figure 136: MEA Glucuronolactone Value Share (%) and BPS Analysis By Form , 2022-2032
Figure 137: MEA Glucuronolactone Y-o-Y Growth (%) Projections By Form , 2022-2032
Figure 138: MEA Glucuronolactone Value (US$ Mn) Analysis by End Use Application, 2017-2032
Figure 139: MEA Glucuronolactone Volume (MT) Analysis by End Use Application, 2017-2032
Figure 140: MEA Glucuronolactone Value Share (%) and BPS Analysis by End Use Application, 2022-2032
Figure 141: MEA Glucuronolactone Y-o-Y Growth (%) Projections by End Use Application, 2022-2032
Figure 142: MEA Glucuronolactone Attractiveness By Form , 2022-2032
Figure 143: MEA Glucuronolactone Attractiveness by End Use Application, 2022-2032
Figure 144: MEA Glucuronolactone Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Food and Beverage Insights
View Reports
